202 related articles for article (PubMed ID: 9931133)
1. Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions.
Natarajan R; Scott S; Bai W; Yerneni KK; Nadler J
Hypertension; 1999 Jan; 33(1 Pt 2):378-84. PubMed ID: 9931133
[TBL] [Abstract][Full Text] [Related]
2. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
[TBL] [Abstract][Full Text] [Related]
3. Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway.
Yoshizumi M; Tsuchiya K; Suzaki Y; Kirima K; Kyaw M; Moon JH; Terao J; Tamaki T
Biochem Biophys Res Commun; 2002 May; 293(5):1458-65. PubMed ID: 12054679
[TBL] [Abstract][Full Text] [Related]
4. Quercetin inhibits Shc- and phosphatidylinositol 3-kinase-mediated c-Jun N-terminal kinase activation by angiotensin II in cultured rat aortic smooth muscle cells.
Yoshizumi M; Tsuchiya K; Kirima K; Kyaw M; Suzaki Y; Tamaki T
Mol Pharmacol; 2001 Oct; 60(4):656-65. PubMed ID: 11562426
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase.
Zohn IE; Yu H; Li X; Cox AD; Earp HS
Mol Cell Biol; 1995 Nov; 15(11):6160-8. PubMed ID: 7565768
[TBL] [Abstract][Full Text] [Related]
6. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
[TBL] [Abstract][Full Text] [Related]
7. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway.
Won SM; Park YH; Kim HJ; Park KM; Lee WJ
Exp Mol Med; 2006 Oct; 38(5):525-34. PubMed ID: 17079869
[TBL] [Abstract][Full Text] [Related]
8. p38 Kinase is a negative regulator of angiotensin II signal transduction in vascular smooth muscle cells: effects on Na+/H+ exchange and ERK1/2.
Kusuhara M; Takahashi E; Peterson TE; Abe J; Ishida M; Han J; Ulevitch R; Berk BC
Circ Res; 1998 Oct; 83(8):824-31. PubMed ID: 9776729
[TBL] [Abstract][Full Text] [Related]
9. Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells.
Xi XP; Graf K; Goetze S; Fleck E; Hsueh WA; Law RE
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):73-82. PubMed ID: 9888869
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms.
Deguchi J; Makuuchi M; Nakaoka T; Collins T; Takuwa Y
Circ Res; 1999 Oct; 85(7):565-74. PubMed ID: 10506481
[TBL] [Abstract][Full Text] [Related]
11. Acrolein activates mitogen-activated protein kinase signal transduction pathways in rat vascular smooth muscle cells.
Ranganna K; Yousefipour Z; Nasif R; Yatsu FM; Milton SG; Hayes BE
Mol Cell Biochem; 2002 Nov; 240(1-2):83-98. PubMed ID: 12487375
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II stimulates p21-activated kinase in vascular smooth muscle cells: role in activation of JNK.
Schmitz U; Ishida T; Ishida M; Surapisitchat J; Hasham MI; Pelech S; Berk BC
Circ Res; 1998 Jun; 82(12):1272-8. PubMed ID: 9648723
[TBL] [Abstract][Full Text] [Related]
13. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients.
Touyz RM; He G; Wu XH; Park JB; Mabrouk ME; Schiffrin EL
Hypertension; 2001 Jul; 38(1):56-64. PubMed ID: 11463760
[TBL] [Abstract][Full Text] [Related]
14. Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.
Nguyen HT; Adam RM; Bride SH; Park JM; Peters CA; Freeman MR
Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1155-67. PubMed ID: 11003596
[TBL] [Abstract][Full Text] [Related]
15. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
16. Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway.
Wilmer WA; Dixon CL; Hebert C
Kidney Int; 2001 Sep; 60(3):858-71. PubMed ID: 11532081
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of cardiac c-jun amino-terminal kinase and extracellular signal-regulated kinase in angiotensin II-mediated hypertension.
Yano M; Kim S; Izumi Y; Yamanaka S; Iwao H
Circ Res; 1998 Oct; 83(7):752-60. PubMed ID: 9758646
[TBL] [Abstract][Full Text] [Related]
18. Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension.
Hamaguchi A; Kim S; Yano M; Yamanaka S; Iwao H
J Am Soc Nephrol; 1998 Mar; 9(3):372-80. PubMed ID: 9513899
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells.
Goetze S; Xi XP; Graf K; Fleck E; Hsueh WA; Law RE
FEBS Lett; 1999 Jun; 452(3):277-82. PubMed ID: 10386606
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin ii-induced signaling in vascular smooth muscle.
Rocic P; Lucchesi PA
J Biol Chem; 2001 Jun; 276(24):21902-6. PubMed ID: 11262415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
